Nikhil Prasad Fact checked by:Thailand Medical News Team Mar 13, 2026 1 hour, 29 minutes ago
Medical News: Experimental Therapy May Protect the Heart After a Heart Attack
A new experimental therapy involving a small peptide known as GHRP-6 may help the heart recover after a heart attack by improving heart function, reducing tissue damage, and slowing harmful changes that occur in the heart muscle. Researchers say the findings could open the door to a new class of treatments aimed at preventing heart failure after a cardiac event.
Medical News Scientists discover experimental peptide that helps damaged hearts recover after a heart attack
Scientists from the Shanghai Institute of Materia Medica at the Chinese Academy of Sciences in China, the Center for Genetic Engineering and Biotechnology in Havana, Cuba, the Center for Surgical and Medical Research in Havana, Cuba, and the China-Cuba Biotechnology Joint Innovation Center in Yongzhou, China collaborated on the research. Their work explored whether GHRP-6 could protect heart tissue and improve cardiac performance after a severe heart attack.
Heart attacks remain one of the leading causes of death worldwide. Even when patients survive the initial event, the damaged heart muscle can gradually weaken and stretch, leading to long-term heart failure. Researchers are therefore searching for therapies that can limit damage and help the heart recover more effectively.
How the Study Was Conducted
To investigate the peptide’s potential, scientists used a well-established laboratory model of heart attack. In the experiment, rats underwent a procedure that permanently blocked a major coronary artery supplying the heart. This produced severe heart damage similar to what occurs in humans after a major heart attack.
The animals were divided into groups. One group received saline as a control treatment, while another group received injections of the peptide GHRP-6 for seven days following the heart attack. The team then assessed heart structure and performance using ultrasound imaging and microscopic examination of heart tissue.
Researchers had previously determined the optimal dose of GHRP-6 for improving heart contraction. They selected a dose of 0.4 milligrams per kilogram, which produced the strongest improvements in cardiac performance without negative side effects.
Significant Improvements in Heart Function
The results were striking. Rats that received only saline experienced severe deterioration in heart performance. Their left ventricular ejection fraction, an important measurement of how effectively the heart pumps blood, fell dramatically.
In contrast, animals treated with GHRP-6 showed substantial improvement in several critical indicators of heart function. These included:
-Increased ejection fraction
-Improved fractional shortening of the heart muscle
-Higher stroke volume
-Reduced enlargement of the heart chamber
The therapy also helped prevent the abnormal widening of the heart’s left ventricle, a major feature of heart failure progression.
Overall, treated animals showed a far healthier heart pumping capacity comp
ared with untreated animals.
Reduced Tissue Damage and Scarring
Microscopic examination of the heart tissue revealed another major benefit. Untreated animals showed extensive cell death, inflammation, and large areas of fibrotic scar tissue.
By contrast, the hearts of GHRP-6 treated animals displayed noticeably less structural damage. The peptide appeared to limit the spread of dead tissue and reduce inflammatory infiltration. Measurements showed an average 27.6 percent reduction in scar-related collagen buildup, suggesting that the therapy helped prevent long-term remodeling of the heart muscle.
These structural improvements were closely linked to the improved heart function observed in the treated animals.
How the Peptide Protects the Heart
To better understand the underlying mechanisms, the researchers conducted a detailed protein analysis of heart mitochondria, the structures responsible for producing cellular energy.
They found that GHRP-6 altered the activity of 191 proteins, many of which are involved in energy production and cell survival. The peptide increased proteins that support fatty acid metabolism and mitochondrial energy generation while boosting antioxidant defenses that protect heart cells from damage.
At the same time, proteins linked to cell death and harmful metabolic pathways were reduced. This suggests the peptide may help heart cells survive stress and produce energy more efficiently during recovery after a heart attack.
This
Medical News report highlights how these coordinated metabolic changes may explain the peptide’s powerful protective effects.
Conclusion
The findings suggest that GHRP-6 could represent a promising new therapeutic strategy for preventing heart failure after a heart attack. By improving heart pumping ability, reducing scarring, and enhancing the heart’s energy-producing systems, the peptide appears to protect cardiac tissue during the critical early recovery phase. Although the research was conducted in animals, the results provide compelling evidence that further studies in humans may be worthwhile. If future trials confirm these benefits, GHRP-6 or related compounds could become an important new tool in the treatment of cardiovascular disease.
The study findings were published in the peer reviewed journal: Pharmaceuticals.
https://www.mdpi.com/1424-8247/19/3/468
For the latest on heart health, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/cardiology
Medical Disclaimer: All content published by Thailand Medical News is based on scientific research and is intended for informational and educational purposes only. It is not medical advice, diagnosis, or treatment. Readers must not attempt to use, apply, or experiment with any protocols, compounds, or therapies mentioned without first consulting a qualified and licensed medical doctor. Many findings discussed are experimental or preliminary, and only a licensed healthcare professional can determine what is safe and appropriate for an individual’s specific medical condition.